Lukas Tometten

532 total citations
7 papers, 49 citations indexed

About

Lukas Tometten is a scholar working on Infectious Diseases, General Health Professions and Oncology. According to data from OpenAlex, Lukas Tometten has authored 7 papers receiving a total of 49 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 2 papers in General Health Professions and 2 papers in Oncology. Recurrent topics in Lukas Tometten's work include COVID-19 Clinical Research Studies (4 papers), COVID-19 and healthcare impacts (2 papers) and Liver Disease and Transplantation (1 paper). Lukas Tometten is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), COVID-19 and healthcare impacts (2 papers) and Liver Disease and Transplantation (1 paper). Lukas Tometten collaborates with scholars based in Germany. Lukas Tometten's co-authors include Norma Jung, Rika Draenert, Siegbert Rieg, Lisa Pilgram, Kai Wille, Stefan Borgmann, Carolin Jakob, Roman‐Ulrich Müller, Lukas Eberwein and Melanie Stecher and has published in prestigious journals such as Infection, Clinical Research in Cardiology and United European Gastroenterology Journal.

In The Last Decade

Lukas Tometten

4 papers receiving 49 citations

Peers

Lukas Tometten

ID

EPIDE

NEURO

SURGE

ONCOL

Wang Zhaoqin China

Mounira Smati-Lafarge France

Sven Kerneis United Kingdom

Ronak Miladi Iran

Hayley Hardwick United Kingdom

Sunday Adesola Nigeria

Songping Huang China

Fen Ai China

Kevin Collins United States

Mahnaz Mozdourian Iran

Wang Zhaoqin China

Lukas Tometten

47 ×1.6

ID

13 ×0.9

EPIDE

19 ×1.5

NEURO

6 ×0.6

SURGE

9 ×1.1

ONCOL

Citations per year, relative to Lukas Tometten Lukas Tometten (= 1×) peers Wang Zhaoqin

Countries citing papers authored by Lukas Tometten

Since Specialization

Citations

This map shows the geographic impact of Lukas Tometten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lukas Tometten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lukas Tometten more than expected).

Fields of papers citing papers by Lukas Tometten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lukas Tometten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lukas Tometten. The network helps show where Lukas Tometten may publish in the future.

Co-authorship network of co-authors of Lukas Tometten

This figure shows the co-authorship network connecting the top 25 collaborators of Lukas Tometten. A scholar is included among the top collaborators of Lukas Tometten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lukas Tometten. Lukas Tometten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Tometten, Lukas, et al.. (2025). Ambulante parenterale antiinfektive Therapie – Herausforderungen und Chancen. Die Innere Medizin. 67(2). 158–165.

2.

Rüthrich, Maria Madeleine, Yascha Khodamoradi, Julia Lanznaster, et al.. (2023). COVID-19 in Patients with Active Cancer: Higher Inflammatory Activity Predicts Poor Outcome. Oncology Research and Treatment. 47(3). 88–96.

3.

Jung, Norma, Lukas Tometten, & Rika Draenert. (2023). Choosing Wisely internationally – helpful recommendations for antimicrobial stewardship!. Infection. 51(3). 567–581. 11 indexed citations

4.

Hanses, Frank, Melanie Stecher, Michael Dreher, et al.. (2022). COVID‐19 mortality in cirrhosis is determined by cirrhosis‐associated comorbidities and extrahepatic organ failure: Results from the multinational LEOSS registry. United European Gastroenterology Journal. 10(4). 409–424. 8 indexed citations

5.

Pilgram, Lisa, Lukas Eberwein, Kai Wille, et al.. (2021). Clinical course and predictive risk factors for fatal outcome of SARS-CoV-2 infection in patients with chronic kidney disease. Infection. 49(4). 725–737. 12 indexed citations

6.

Tometten, Lukas, Stefan Borgmann, Jochen Schneider, et al.. (2020). COVID-19 in cancer patients: Clinical characteristics and outcome - a first analysis of the LEOSS registry. Kölner Universitäts PublikationsServer (Universität zu Köln).

7.

Cremer, Sebastian, Carolin Jakob, Alexander Berkowitsch, et al.. (2020). Elevated markers of thrombo-inflammatory activation predict outcome in patients with cardiovascular comorbidities and COVID-19 disease: insights from the LEOSS registry. Clinical Research in Cardiology. 110(7). 1029–1040. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact